Ethacizine
CARDIOVASCULAR SYSTEM
Also known as: etacizin, ethacizin, ethacizine HCl, ethacizine hydrochloride
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Ethacizine is a drug catalogued in DrugCentral. Recorded indications include Supraventricular arrhythmia and Ventricular arrhythmia.
- Indications: Supraventricular arrhythmia and Ventricular arrhythmia.
- ATC code: C01BC09 (Antiarrhythmics, class Ic).
- Molecular formula: C22H27N3O3S; molecular weight 413.54 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Supraventricular arrhythmia
- Ventricular arrhythmia
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C01BC09 | CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › ANTIARRHYTHMICS, CLASS I AND III › Antiarrhythmics, class Ic |
Chemical structure
| Molecular formula | C22H27N3O3S |
|---|---|
| Molecular weight | 413.54 g/mol |
| CAS number | 33414-33-4 |
| InChIKey | PQXGNJKJMFUPPM-UHFFFAOYSA-N |
| PubChem CID | 107841 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Ethacizine used for?
DrugCentral lists the following indications for Ethacizine: Supraventricular arrhythmia and Ventricular arrhythmia.
What is the chemical formula of Ethacizine?
Ethacizine has the molecular formula C22H27N3O3S and a molecular weight of 413.54 g/mol.
Browse: all drugs starting with E · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4835 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1997663 — compound record and bioactivity
- PubChem CID 107841 — chemical identifiers
- DrugBank DB13645 — drug record
- FDA UNII FE5SPV1Z6G — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.